Pharma Journalist - Page 871 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Intellipharma reports Par Pharma additional strengths launch of generic Focalin XR

Hebron Technology wins design and implementation project Bid at Tianjin Chas esun

Astrazeneca’s Bydureon EXSCEL trial meets primary safety objective in type-2 diabetes patients

GB Sciences Files Patent Application for Chronic Pain and Heart Therapies based on MCCM

AstraZeneca selects DNAnexus’s cloud based platform for CGR

Atox Bio: Reltecimod passes Futility Analysis and will continue Phase 3

Tom Privette Joins Acurian as VP and head of global Business Development

Debiopharm International acquires clinical-stage ADC, ImmunoGen’s IMGN529/Debio 1562

Palladio Biosciences acquires global rights to develop Lixivaptan

CROS NT Extend Medidata pact to deploy Medidata’s next-gen EDC and RTSM systems